Author: Magro, Fernando; Abreu, Candida; Rahier, Jean-François
Title: The daily impact of COVID-19 in gastroenterology Cord-id: 8dlqow9n Document date: 2020_4_11
ID: 8dlqow9n
Snippet: A new strain of coronavirus, called SARS-CoV-2, emerged in Wuhan, China, in December 2019, probably originating from a wild-animal contamination. Since then, the situation rapidly evolved from a cluster of patients with pneumonia, to a regional epidemic and now to a pandemic called COrona VIrus Disease 2019 (COVID-19). This evolution is related to the peculiar modes of transmission of the disease and to the globalization and lifestyle of the 21st century that created the perfect scenario for vir
Document: A new strain of coronavirus, called SARS-CoV-2, emerged in Wuhan, China, in December 2019, probably originating from a wild-animal contamination. Since then, the situation rapidly evolved from a cluster of patients with pneumonia, to a regional epidemic and now to a pandemic called COrona VIrus Disease 2019 (COVID-19). This evolution is related to the peculiar modes of transmission of the disease and to the globalization and lifestyle of the 21st century that created the perfect scenario for virus spread. Even though research has not evidenced particular susceptibility of inflammatory bowel disease (IBD) patients to SARS-CoV-2 infection, immunosuppressive and immunomodulatory treatments were considered potential risk factors. In this context, initiating treatments with these agents should be cautiously weighted and regular ongoing treatments shall be continued, while the dose of corticosteroids should be reduced whenever possible. Due to the increased risk of contamination, elective endoscopic procedures and surgeries should be postponed and IBD online appointments shall be considered. IBD patients shall also follow the recommendations provided to the general population, such as minimization of contact with infected or suspected patients and to wash hands frequently. In the absence of effective treatments and vaccines, this pandemic can only be controlled through prevention of SARS-CoV-2 transmission with the main objectives of providing patients the best healthcare possible and reduce mortality.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and liver cell: 1, 2
- acute ards respiratory distress syndrome and liver cirrhosis: 1, 2
- acute ards respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute ards respiratory distress syndrome and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute ards respiratory distress syndrome and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
- acute ards respiratory distress syndrome and liver transplant: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and liver transplant patient: 1
- acute ards respiratory distress syndrome and long period: 1, 2
- acute ards respiratory distress syndrome and long severe: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute ards respiratory distress syndrome and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- acute ards respiratory distress syndrome and low respiratory tract: 1, 2
- acute gastrointestinal bleeding and liver cirrhosis: 1
- acute gastrointestinal bleeding and liver failure: 1, 2
- acute pneumonia and additional risk: 1, 2, 3, 4
- acute pneumonia and liver cell: 1, 2, 3, 4
- acute pneumonia and liver cirrhosis: 1, 2, 3
- acute pneumonia and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute pneumonia and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute pneumonia and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
Co phrase search for related documents, hyperlinks ordered by date